TD Asset Management Inc decreased its position in The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 5.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 758,694 shares of the medical device company’s stock after selling 45,915 shares during the period. TD Asset Management Inc owned about 0.38% of Cooper Companies worth $52,016,000 as of its most recent SEC filing.
A number of other large investors have also bought and sold shares of COO. CYBER HORNET ETFs LLC purchased a new position in shares of Cooper Companies during the 2nd quarter valued at $36,000. MUFG Securities EMEA plc purchased a new stake in Cooper Companies during the second quarter valued at about $42,000. Assetmark Inc. boosted its position in Cooper Companies by 357.8% during the second quarter. Assetmark Inc. now owns 618 shares of the medical device company’s stock worth $44,000 after purchasing an additional 483 shares during the period. Quent Capital LLC purchased a new position in shares of Cooper Companies in the third quarter worth about $44,000. Finally, Mather Group LLC. bought a new stake in shares of Cooper Companies in the third quarter valued at approximately $56,000. 24.39% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other news, Director Lawrence Erik Kurzius purchased 2,000 shares of the stock in a transaction on Wednesday, December 17th. The shares were acquired at an average price of $82.50 per share, for a total transaction of $165,000.00. Following the completion of the transaction, the director directly owned 7,777 shares of the company’s stock, valued at approximately $641,602.50. This trade represents a 34.62% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Also, CEO Albert G. White III acquired 10,000 shares of the business’s stock in a transaction dated Tuesday, December 16th. The stock was purchased at an average price of $80.80 per share, with a total value of $808,000.00. Following the completion of the acquisition, the chief executive officer directly owned 236,151 shares in the company, valued at approximately $19,081,000.80. This represents a 4.42% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased 16,014 shares of company stock valued at $1,304,416 over the last quarter. Insiders own 1.98% of the company’s stock.
Analysts Set New Price Targets
Cooper Companies Stock Performance
NASDAQ:COO opened at $84.01 on Friday. The stock has a market cap of $16.39 billion, a P/E ratio of 44.69, a PEG ratio of 2.38 and a beta of 1.03. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30. The business’s 50-day moving average price is $82.25 and its two-hundred day moving average price is $75.61. The Cooper Companies, Inc. has a twelve month low of $61.78 and a twelve month high of $92.84.
Cooper Companies (NASDAQ:COO – Get Free Report) last posted its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. The company had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.06 billion. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. Cooper Companies’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the prior year, the business earned $1.04 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. As a group, equities analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.
About Cooper Companies
Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
Recommended Stories
- Five stocks we like better than Cooper Companies
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
